Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

SHAO Wei, SHU Lixin, LI Jiewei. Comparison of the drug for infection prevention in combat injuries between the PLA and USA Armed Force[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(1): 71-73. doi: 10.3969/j.issn.1006-0111.2014.01.020
Citation: SHAO Wei, SHU Lixin, LI Jiewei. Comparison of the drug for infection prevention in combat injuries between the PLA and USA Armed Force[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(1): 71-73. doi: 10.3969/j.issn.1006-0111.2014.01.020

Comparison of the drug for infection prevention in combat injuries between the PLA and USA Armed Force

doi: 10.3969/j.issn.1006-0111.2014.01.020
  • Received Date: 2013-12-20
  • Rev Recd Date: 2014-01-05
  • Objective To compare the differences in the drug utilization for infection prevention in combat injuries between the PLA and USA armed force. Methods The guidelines for the prevention of infections associated with combat-related injuries and tactical medical emergency protocols of USA armed force were compared with the combat injury treatment regulation of PLA. Results There are some differences between the prevention and medicine use of war injure infection of Chinese and American Armed Force, especially in variety selection and principle of drug selection in different echelon. Conclusion The references could be taken from the principle of drug utilization of prevention and treatment in combat injuries from USA Armed Force.
  • [1] 总后勤部卫生部.战伤分类及判断标准[S].2007:1.
    [2] 扈长茂,陈国良,贺 祥.军队卫生勤务学[M].上海:第二军医大学出版社,2007:37.
    [3] Duane R, Clinton K, Romney C,et al.Executive summary:guidelines for the prevention of infections associated with combat-related injuries:2011 update[J].J Trauma,2011(71):202-209.
    [4] 总后勤部卫生部.战伤救治规则[S].2006:1.
    [5] U.S. Special Operations Command. Tactical medical emergency protocols for special operations advanced tactical practitioners (ATPs)[J].J Spec Oper Med,2010:1-179.
    [6] 张永信.根据药物在不同部位的浓度选择抗菌药[J].中国社区医师,2013(7):20.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Article Metrics

Article views(2326) PDF downloads(67) Cited by()

Related
Proportional views

Comparison of the drug for infection prevention in combat injuries between the PLA and USA Armed Force

doi: 10.3969/j.issn.1006-0111.2014.01.020

Abstract: Objective To compare the differences in the drug utilization for infection prevention in combat injuries between the PLA and USA armed force. Methods The guidelines for the prevention of infections associated with combat-related injuries and tactical medical emergency protocols of USA armed force were compared with the combat injury treatment regulation of PLA. Results There are some differences between the prevention and medicine use of war injure infection of Chinese and American Armed Force, especially in variety selection and principle of drug selection in different echelon. Conclusion The references could be taken from the principle of drug utilization of prevention and treatment in combat injuries from USA Armed Force.

SHAO Wei, SHU Lixin, LI Jiewei. Comparison of the drug for infection prevention in combat injuries between the PLA and USA Armed Force[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(1): 71-73. doi: 10.3969/j.issn.1006-0111.2014.01.020
Citation: SHAO Wei, SHU Lixin, LI Jiewei. Comparison of the drug for infection prevention in combat injuries between the PLA and USA Armed Force[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(1): 71-73. doi: 10.3969/j.issn.1006-0111.2014.01.020
Reference (6)

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return